Somatic structural variation targets neurodevelopmental genes and identifies SHANK2 as a tumor suppressor in neuroblastoma

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 3.
Figure 3.

Identification of recurrently altered genes in neuroblastoma by breakpoint analyses. (AF) Recurrently altered genes ranked based on different breakpoint analyses and mode of impact: (A) gene coding sequences with recurrent SJ-BPs; (B) gene proximal and intronic sequences with recurrent SJ-BPs; (C) gene proximal sequences with recurrent RD-BPs; (D) gene coding sequences with recurrent RD-BPs; (E) gene coding sequences with recurrent CN-BPs; and (F) gene proximal sequences with recurrent CN-BPs. (G) OncoPrint based on the WGS data set recurrently altered genes by SVs detected through orthogonal approaches (SJ-BP and RD-BP) as depicted in bar plot (right). The oncoPrint aggregates three tracks per gene representing different BP analysis: (upper) SJ-BP; (center) RD-BP; and (lower) recurrent pathogenic SNVs.

This Article

  1. Genome Res. 30: 1228-1242

Preprint Server